Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01964599 · ClinicalTrials.gov registry record · NA
Potato Fiber and Gastrointestinal Function: Phase 3
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT01964599: Completed NA study, sponsored by University of Florida.
NCT01964599 is a NA study that has completed, run by University of Florida. The registered enrollment target is 90 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01964599, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
The primary physiological impacts of fiber intake include the gastrointestinal effects of stool bulking, increased stool frequency and decreased gastrointestinal transit time (GTT). Fermentation of resistant starches by microbiota increases bacterial numbers, which increases fecal bulk and may impact frequency and transit time. The purpose of this study is to determine the effects of resistant potato starches (potato fiber) on stool frequency, transit time and microbiota in healthy individuals.
Primary Outcome
Change in stool frequency determined by the daily questionnaire
Interventions
- DIETARY_SUPPLEMENT Control
- DIETARY_SUPPLEMENT PF-RS
- DIETARY_SUPPLEMENT PF-RO1
- DIETARY_SUPPLEMENT PF-RO2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2014-01 |
| Est. Completion | 2014-04 |
| Phase | NA |
What the finished NCT01964599 record still lists
NCT01964599 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 4 interventions - of which Control is the first listed.
NCT01964599 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01964599 about?
NCT01964599 is a clinical study titled "Potato Fiber and Gastrointestinal Function: Phase 3". The primary physiological impacts of fiber intake include the gastrointestinal effects of stool bulking, increased stool frequency and decreased gastrointestinal transit time (GTT). Fermentation of resistant starches by microbiota increases bacterial numbers, which increases fecal bulk and may impac...
What is the current status of trial NCT01964599?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2014-01. Estimated completion is 2014-04.
What interventions are being tested in trial NCT01964599?
The interventions under investigation include: Control (DIETARY_SUPPLEMENT), PF-RS (DIETARY_SUPPLEMENT), PF-RO1 (DIETARY_SUPPLEMENT), PF-RO2 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01964599?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01964599's enrollment target sits among peer trials
90 941st of 2000 higher than 1,029 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia